Business
Hardman Res: Hep-C point-of-care test launched
Hardman Res: Hep-C point-of-care test launched.
About this update from Genedrive Plc
[{"type":"text","content":"\n \nRNS Number : 2829C Genedrive PLC 18 January 2018 \n\nHardman Res: Hep-C point-of-care test launched\nHepatitis C point-of-care diagnostic launched - genedrive plc is a commercial-stage company focused on point-of-care/need molecular diagnostics and biomarkers. Its Genedrive® molecular diagnostic testing platform is at the forefront of this technology, offering a rapid, low-cost, simple-to-use device with high sensitivity and specificity in infectious disease diagnosis. Rapid analysis of patient samples greatly aids clinical and public health decision- making, with field testing particularly important in emerging markets. Hepatitis C diagnosis is a multi-million-dollar market opportunity; the company launched its Genedrive HCV ID Kit in 1H'18 at the IFCC World Lab conference in South Africa.\nPlease click here for the full report:\nhttp://hardmanandco.com/docs/default-source/company-docs/genedrive-plc-documents/18.01.18-hepatitis-c-point-of-care-diagnostic-launched.pdf\n\n\n\n\nTo contact us:\nHardman & Co\n35 New Broad Street\nLondon\nEC2M 1NH\nwww.hardmanandco.com\nFollow us on Twitter @HardmanandCo\n\n\nContacts:\nDr Martin Hall\nDr Dorothea Hill\nDr Gregoire Pave\n\n+44 20 7194 7622\n\n\n \[email protected]@[email protected]\n\n\n\n\nAbout Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.\nHardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.\nOur research is provided for the use of the professional investment community, market counterparties and sophisticated and h...